This HTML5 document contains 194 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1056/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q53098804
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel articolo scientifico 2017年學術文章 teaduslik artikkel artigo científico ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ наукова стаття, опублікована в серпні 2017 2017年學術文章 artykuł naukowy bài báo khoa học مقالهٔ علمی מאמר מדעי article scientific 2017年學術文章 artículu científicu vitskapeleg artikkel artigo científico (publicado na 2017) article scientifique (publié 2017) 2017年学术文章 2017年學術文章 scienca artikolo tieteellinen artikkeli 2017年學術文章 2017 nî lūn-bûn مقالة علمية 2017年学术文章 artikulong pang-agham scientific article 2017年学术文章 2017年学术文章 vitenskapelig artikkel научная статья mokslinis straipsnis επιστημονικό άρθρο tudományos cikk บทความทางวิทยาศาสตร์ 2017년 논문 научни чланак 2017年学术文章 article científic мақолаи илмӣ videnskabelig artikel (udgivet 2017) سائنسی مضمون мақолаи илмӣ artigo científico (publicado na 2017) artikull shkencor wissenschaftlicher Artikel wetenschappelijk artikel vědecký článek գիտական հոդված bilimsel makale articol științific naučni članak научна статия 2017年の論文 научни чланак vedecký článok სამეცნიერო სტატია 2017年學術文章 artículo científico publicado en 2017
p:P577
wds:Q53098804-E48E2994-6248-4A77-9C66-C9194A333192
wdt:P577
2017-08-27T00:00:00Z
p:P407
wds:Q53098804-E284F863-1DAE-4357-9EB8-4A09E5AF8174
wdt:P407
wd:Q1860
p:P2093
wds:Q53098804-6EA92DF2-4BFA-4714-9671-023588AC2EA9 wds:Q53098804-7A40F312-4E78-4472-93C0-6EF998C6617D wds:Q53098804-8CBE7F13-A650-4098-9342-12A66F20FAAA wds:Q53098804-8B3488AB-7362-4695-85F9-37EDB650E6F7 wds:Q53098804-218F6B05-640B-4CEE-8D0B-47FA848352F4 wds:Q53098804-4D2DA6A6-AD48-45F7-8DCA-90013FD7616A wds:Q53098804-5AEFDB00-F557-43D8-89B5-153966D9508D wds:Q53098804-5C125792-92F9-4D3F-92F0-D633162AA1D1 wds:Q53098804-0625453D-BADA-43B9-9D51-FAE29DB79152 wds:Q53098804-14E88E91-9E02-4237-A009-F864EDEFB0D0 wds:Q53098804-1C7185BF-6022-4FC1-B340-C5035C17B19D wds:Q53098804-17F9490F-20BD-44F4-8CA8-BC22D8DCD994 wds:Q53098804-AFD80738-E9F5-49CB-AB7E-D4897E83E01C
wdt:P2093
Dragos Vinereanu Jae-Hyung Kim Antonio L Dans Ajay K Kakkar Robert G Hart Rafael Diaz Basil S Lewis Lars Ryden Yan Liang Stuart J Connolly Jun Zhu Alexander N Parkhomenko Georg Ertl
rdfs:label
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
skos:prefLabel
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
schema:name
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
p:P50
wds:Q53098804-8A101F49-9604-4198-8015-42F2AC1D3BAE wds:Q53098804-9177868B-1E2A-4B2C-B92C-75746598BBBC wds:Q53098804-9A85FE35-CBCB-40B7-A554-BC9429DF6DC4 wds:Q53098804-9AC2F123-A129-415B-B4FF-6F5F69BB3FA5 wds:Q53098804-9B0C86DB-4890-49DA-B8DE-773712D859BF wds:Q53098804-5E02E590-2DF4-4188-85C3-177192046944 wds:Q53098804-6EBA46D7-33D8-4F61-ADA3-A056FF1EDBC7 wds:Q53098804-6ED18F82-402A-457C-81D6-B3732B6B12A3 wds:Q53098804-70A68C31-D4FD-446B-BE87-5768BEA91DEF wds:Q53098804-8945A32C-4313-4024-804D-E11513544E35 wds:Q53098804-3ED695BA-E16B-4099-8497-730B5FF3EF13 wds:Q53098804-51BE9A58-56FC-44B0-A367-363BA4F033E1 wds:Q53098804-58DB71A1-10B8-4E04-93F1-8C0AD5B31365 wds:Q53098804-2100306F-C9D7-48EF-92FA-CEBE44326E13 wds:Q53098804-286DBC53-1E5C-48A6-91D1-5103934FF7ED wds:Q53098804-2D5EB011-E7F6-423A-B6C6-A62F593689BA wds:Q53098804-2EF98BAA-6041-4A14-BD4E-A2ADF300F21A wds:Q53098804-377B60BC-8494-42DA-87EE-FCBC17CC9379 wds:Q53098804-396911C3-4E1D-4272-845B-7F2E79391877 wds:Q53098804-CE9E9F6B-6588-41B9-80F4-3F85B5677199 wds:Q53098804-D8726DE8-D269-4A4D-A04F-591409DEA763 wds:Q53098804-DF9FC75C-9042-45E8-A0AE-D4109AF3A999 wds:Q53098804-A46823D1-15D9-4D2F-A2EB-B367E877B426 wds:Q53098804-AA1327C6-F39F-43EA-8E9B-F8464C385A53 wds:Q53098804-AA3190C3-7F33-4009-B6AF-8BB30EEDEB41 wds:Q53098804-B0D9F848-6C75-460C-A903-D708FA7B6225 wds:Q53098804-BEA76DBF-807A-4719-AB4F-DCD10D3B5F3D wds:Q53098804-C28292C0-12C8-4458-A733-9474EF306423 wds:Q53098804-C4571DC7-BE17-48F1-B7F2-2F0243C82820 wds:Q53098804-0735399F-83C9-4A27-9571-72CC2A00B8EA wds:Q53098804-0CAE9550-A845-4A2C-BA56-0D7F87738A2C wds:Q53098804-161AC6FB-8B88-448C-A9D8-C7C8D0D5BE06 wds:Q53098804-19947BDB-4B8D-4056-8E90-078633BFB1B1 wds:Q53098804-03A05EDC-9515-4830-A38A-6EA702F64EBF wds:Q53098804-03DEFE3B-2714-4E0A-A8DB-DB78E0FD0398 wds:Q53098804-042EC5D1-9000-43DF-ABF6-ACC69B4CCA38 wds:Q53098804-05197B91-8BB0-48A5-A6BB-925D7CB638ED
wdt:P50
wd:Q112545568 wd:Q114321733 wd:Q2214381 wd:Q114427111 wd:Q114427083 wd:Q60629666 wd:Q67220498 wd:Q28823540 wd:Q12045089 wd:Q59193850 wd:Q91746153 wd:Q114408626 wd:Q90076716 wd:Q91408152 wd:Q48865428 wd:Q47264894 wd:Q37392962 wd:Q114402800 wd:Q16027739 wd:Q90670192 wd:Q42846212 wd:Q125315761 wd:Q59702676 wd:Q88628895 wd:Q83749854 wd:Q114427060 wd:Q72227369 wd:Q53094713 wd:Q114443555 wd:Q33310590 wd:Q114447955 wd:Q92297294 wd:Q114426404 wd:Q114447957 wd:Q40310748 wd:Q114407439 wd:Q46209817
p:P1476
wds:Q53098804-15269AF5-94AF-490A-B229-4B0CF39026B9
wdt:P1476
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
p:P304
wds:Q53098804-7659FF49-D01D-4D9B-BCF8-E4FF3C8A7E01
wdt:P304
1319-1330
p:P31
wds:Q53098804-531F5353-76C2-4708-B4FE-E6604B8D59C7
wdt:P31
wd:Q13442814
p:P921
wds:Q53098804-955C20B7-AC98-433D-991A-C370DB04CD46 wds:Q53098804-F55AFDCA-0D4D-4D0D-A07F-2D4467B68E4F
wdt:P921
wd:Q389735 wd:Q18216
p:P698
wds:Q53098804-F47A6EAC-A09F-4438-AB65-8829D6EA4263
wdtn:P698
n11:28844192
wdt:P698
28844192
p:P1433
wds:Q53098804-3B4560AA-43AE-4DF3-87A9-ADC4C35AB9C7
wdt:P1433
wd:Q582728
p:P433
wds:Q53098804-ED0757F7-68D6-4DEB-AD7F-3C764F097C6A
p:P478
wds:Q53098804-FA6289AA-4F6A-4357-9B71-8B05D595EC4F
wdt:P433
14
wdt:P478
377
p:P356
wds:Q53098804-4D0EBC71-3E7D-4151-BDB1-82AB0AC66971
wdtn:P356
n10:NEJMOA1709118
wdt:P356
10.1056/NEJMOA1709118
skos:altLabel
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease